| Jenna Ray Griffin, MS, CFY-SLP | |
|
2900 12th Ave N, Suite 10w, Billings, MT 59101-7506 | |
| (406) 238-6400 | |
| (406) 238-6464 |
| Full Name | Jenna Ray Griffin |
|---|---|
| Gender | Female |
| Speciality | Qualified Speech Language Pathologist |
| Experience | 10 Years |
| Location | 2900 12th Ave N, Billings, Montana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427464528 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SLP-SP-TMP-4059 (Montana) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Montana | 7719899889 | 9 |
News Archive
An investigational drug that combats ovarian cancer by inhibiting the formation of new blood vessels has shown promise in a phase II trial, according to a presentation at the 33rd Congress of the European Society for Medical Oncology (ESMO) in Stockholm.
Richmond Private Equity Group Limited announced today that its "portfolio company", National Med Care Ltd, a Salt Lake City Utah, based pharmaceutical marketing firm has entered into an agreement with Taking You Forward Inc., a Cebu Philippines based BPO firm to form a joint venture for the marketing of its compound pharmaceutical products in the United States.
Mount Sinai Medical Center is among the nation's top hospitals for the fifth year in a row according to U.S. News & World Report's 2011-2012 Best Hospitals. Mount Sinai was the only hospital in South Florida to receive a prestigious national ranking in geriatric care and one of only three hospitals in South Florida to rank on a national level.
Neuroblastoma is a childhood cancer, most commonly affecting children aged between 2 -3 and can be fatal. Since the tumor cells resemble certain cells in the adrenal glands, a joint research group from MedUni Vienna's Center for Brain Research and the Swedish Karolinska Institute investigated the cellular origin of these cells and sympathetic neurons during the embryonic development of human adrenal glands.
eMix, a new business venture incubated by DR Systems, today announced an additional list of medical facilities that are taking part in beta trials of eMix, the cloud-based technology for sharing imaging studies and reports. Earlier, eMix had announced a partial list of participating facilities.
› Verified 5 days ago
| Provider Name | University Of Montana |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1578585592 PECOS PAC ID: 7719899889 Enrollment ID: O20031105000735 |
News Archive
An investigational drug that combats ovarian cancer by inhibiting the formation of new blood vessels has shown promise in a phase II trial, according to a presentation at the 33rd Congress of the European Society for Medical Oncology (ESMO) in Stockholm.
Richmond Private Equity Group Limited announced today that its "portfolio company", National Med Care Ltd, a Salt Lake City Utah, based pharmaceutical marketing firm has entered into an agreement with Taking You Forward Inc., a Cebu Philippines based BPO firm to form a joint venture for the marketing of its compound pharmaceutical products in the United States.
Mount Sinai Medical Center is among the nation's top hospitals for the fifth year in a row according to U.S. News & World Report's 2011-2012 Best Hospitals. Mount Sinai was the only hospital in South Florida to receive a prestigious national ranking in geriatric care and one of only three hospitals in South Florida to rank on a national level.
Neuroblastoma is a childhood cancer, most commonly affecting children aged between 2 -3 and can be fatal. Since the tumor cells resemble certain cells in the adrenal glands, a joint research group from MedUni Vienna's Center for Brain Research and the Swedish Karolinska Institute investigated the cellular origin of these cells and sympathetic neurons during the embryonic development of human adrenal glands.
eMix, a new business venture incubated by DR Systems, today announced an additional list of medical facilities that are taking part in beta trials of eMix, the cloud-based technology for sharing imaging studies and reports. Earlier, eMix had announced a partial list of participating facilities.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jenna Ray Griffin, MS, CFY-SLP 926 6th Ave, Laurel, MT 59044-1916 Ph: (406) 238-6400 | Jenna Ray Griffin, MS, CFY-SLP 2900 12th Ave N, Suite 10w, Billings, MT 59101-7506 Ph: (406) 238-6400 |
News Archive
An investigational drug that combats ovarian cancer by inhibiting the formation of new blood vessels has shown promise in a phase II trial, according to a presentation at the 33rd Congress of the European Society for Medical Oncology (ESMO) in Stockholm.
Richmond Private Equity Group Limited announced today that its "portfolio company", National Med Care Ltd, a Salt Lake City Utah, based pharmaceutical marketing firm has entered into an agreement with Taking You Forward Inc., a Cebu Philippines based BPO firm to form a joint venture for the marketing of its compound pharmaceutical products in the United States.
Mount Sinai Medical Center is among the nation's top hospitals for the fifth year in a row according to U.S. News & World Report's 2011-2012 Best Hospitals. Mount Sinai was the only hospital in South Florida to receive a prestigious national ranking in geriatric care and one of only three hospitals in South Florida to rank on a national level.
Neuroblastoma is a childhood cancer, most commonly affecting children aged between 2 -3 and can be fatal. Since the tumor cells resemble certain cells in the adrenal glands, a joint research group from MedUni Vienna's Center for Brain Research and the Swedish Karolinska Institute investigated the cellular origin of these cells and sympathetic neurons during the embryonic development of human adrenal glands.
eMix, a new business venture incubated by DR Systems, today announced an additional list of medical facilities that are taking part in beta trials of eMix, the cloud-based technology for sharing imaging studies and reports. Earlier, eMix had announced a partial list of participating facilities.
› Verified 5 days ago
Mrs. Brooke Leigh Oftedal, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1750 Morocco Dr, Billings, MT 59105 Phone: 406-671-1854 | |
Jessica Potter, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1597 Avenue D Ste 4, Billings, MT 59102 Phone: 406-690-6996 | |
Kathryn Marie Satterfield, MCSDCCCSLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3940 Rimrock Rd, Billings, MT 59102 Phone: 406-655-5658 Fax: 406-655-5639 | |
Emily Berendts Anderson, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2800 10th Ave N, Billings, MT 59101 Phone: 406-238-2500 | |
Latisha Lee Montgomery, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1233 N 30th St, Billings, MT 59101 Phone: 406-237-7166 | |
Rock Creek Teletherapy, Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1302 24th St W, Suite 132, Billings, MT 59102 Phone: 888-241-4332 Fax: 406-794-0454 | |
Kelly Marie Geary Ruggles, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 708 Broadwater Ave, Billings, MT 59101 Phone: 406-259-1680 Fax: 406-259-1777 |